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ABSTRACT:  Interferon–γ (IFN–γ) has been suggested to play an important role in the 
pathogenesis of malaria. To examine possible association of the IFN–γ receptor 1 
(IFNGR1) polymorphisms with cerebral malaria, 312 adult patients with Plasmodium 
falciparum malaria (203 mild and 109 cerebral malaria patients) living in northwest 
Thailand were genotyped for six single nucleotide polymorphisms (SNPs) including 
-56T/C (rs2234711) and a microsatellite marker in IFNGR1. A case-control association 
analysis failed to detect significant association between the IFNGR1 polymorphisms and 
cerebral malaria, thus implying that the IFNGR1 polymorphism may not be a major 
genetic factor influencing the development of cerebral malaria in the Thai population. 
These data also provide useful information for future genetic studies of IFNG 
polymorphisms in Thai patients. 
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1. Introduction 
Plasmodium falciparum malaria is one of the most deadly infectious diseases for humans. 
Among the severe complications of P. falciparum malaria infection, cerebral malaria 
accounts for vast majority of death from P. falciparum malaria. Sequestration of parasites 
in the small blood vessels of the brain has been suggested to be involved in cerebral 
malaria (Miller et al. 2002). Accumulation of infected erythrocytes induces inflammatory 
reactions mediated by pro-inflammatory cytokines, which damage cerebral endothelial 
cells and affect functions of the nervous system. Abundant production of interferon 
(IFN)–γ, a major pro-inflammatory cytokine, is observed during clinical episodes of malaria 
(Kwiatkowski et al. 1990). IFN- γ and its receptor therefore may play a crucial role in 
development of cerebral malaria. 
The receptor for IFN- γ consists of α and β subunits. The α subunit (encoded by the 
gene IFNGR1; OMIM 107470) is essential for IFN- γ binding, receptor trafficking, and 
signal transduction (Bach et al. 1997). Two functional polymorphisms, IFNGR1 -56T/C 
and IFNGR1 -470insTT/delTT, have been identified in the promoter region of IFNGR1 
(Juliger et al. 2003; Koch et al. 2006; Rosenzweig et al. 2004). In Gambia, heterozygote of 
IFNGR1 -56T/C is associated with protection against cerebral malaria, whereas IFNGR1 
-470delTT allele is associated with protection against severe malaria in general (Koch et 
al. 2002). Recently, significant association of haplotypes comprising the IFNGR1 
promoter polymorphisms with susceptibility to post-kala-azar dermal leishmaniasis was 
reported in Sudan (Salih et al. 2007). This study investigated whether the polymorphisms 
of IFNGR1 influence the susceptibility to cerebral malaria in Thai malaria patients. 
 
2. Materials and Methods 
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2.1 Subjects 
A total of 312 adult patients with P. falciparum malaria (203 mild malaria and 109 cerebral 
malaria) living in northwest Thailand were analyzed in this study. All patients were 
self-reported Thais and underwent treatment at the Hospital for Tropical Diseases, 
Faculty of Tropical Medicine, Mahidol University. Malarial infection by P. falciparum was 
confirmed in all patients by a positive blood smear for the asexual form of P. falciparum. 
Clinical manifestations of malaria were classified according to the definitions and 
associated criteria by the World Health Organization. Cerebral malaria was defined as 
unrousable coma, a positive result in tests for the presence of an asexual form of P. 
falciparum, and exclusion of other causes of coma. Mild malaria was defined as having a 
positive blood smear and fever without other causes of infection and no signs indicating 
severe malaria such as high parasitemia (> 100,000 parasites/ml), hypoglycemia (glucose 
level < 22 nmol/L), severe anemia (hematocrit < 20% or hemoglobin level < 7.0 g/dl) or 
increased serum level of creatinine (> 3.0 mg/dl). All individuals were 13 years old or older, 
and the mean ages of patients with mild malaria and cerebral malaria patients were 25.5 
and 28.6 respectively. This study was approved by the institutional review board of the 
Faculty of Tropical Medicine, Mahidol University, and the Research Ethics Committee of 
the Graduate School of Comprehensive Human Sciences, University of Tsukuba. 
Informed consent was obtained from all patients. 
 
2.2 DNA extraction, variation screening, and genotyping 
Genomic DNAs from all the patients were purified from peripheral blood leukocytes using 
a commercially available kit (QIAmp blood kit; Qiagen, Hilden, Germany). A variation 
screening for the entire seven exons of the IFNGR1 gene was performed in 16 mild and 
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16 cerebral malaria patients (protocols and primer sequences are available upon request). 
In Fig. 1A, the region subjected to variation screening is indicated by shaded bar. 
Accordingly, six SNPs, -56C/T (rs2234711), IVS6-4A/G (rs3799488), 1050T/G (rs11914), 
1400T/C (rs1887415), 1676A/G (rs1887416), and 1687T/A (rs1887417), were identified. 
These six SNPs and a microsatellite marker (corresponding to rs59020499) in intron 5 of 
IFNGR1 were genotyped for the remaining malaria patients. The protocols and primer 
sequences are available upon request. 
 
2.3 Statistical analysis 
Deviation from Hardy-Weinberg equilibrium for each malaria group was assessed by the 
exact P-value obtained from a Monte Carlo simulation. The simulations were performed 
using the SNPAlyze software package ver. 7.0 (Dynacom). The differences in genotype 
and allele frequencies between cerebral and mild malaria patients were examined by 
Fisher’s exact probability test. In association test, three modes of inheritance (i.e., 
dominance, recessive, and additive) were also evaluated by Fisher’s exact probability test 
or trend test.  For a microsatellite marker with multiple alleles, the P-value was calculated 
for each allele based on a 2 x 2 table (i.e., focused allele vs. the other alleles). Haplotype 
frequencies and pairwise linkage disequilibrium (LD) parameters, |D’| and r2, between 
SNPs were estimated based on the expectation-maximization algorithm. The SNP 
haplotype frequencies were also compared between cerebral and mild malaria patients by 
a permutation test. The calculations of haplotype frequencies and LD parameters were 
performed with the Haploview software version 4.0 (Barrett et al. 2005). The power 
calculations were conducted as described elsewhere (Ohashi and Tokunaga 2002; 
Ohashi et al. 2001). 
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3. Results and Discussion 
A variation screening for the IFNGR1 gene identified six SNPs in 32 Thai patients with 
malaria (Fig. 1A). These SNPs were genotyped for all the patients. Table 1 shows the 
genotype and allele frequencies of the IFNGR1 SNPs in cerebral and mild malaria 
patients. Association tests revealed that none of the SNPs was associated with cerebral 
malaria. According to previous studies (Juliger et al. 2003; Koch et al. 2002; Koch et al. 
2006), among SNPs analyzed in this study, -56C/T is the most plausible candidate for 
showing the association with susceptibility to cerebral malaria. The power calculation 
suggested that the present sample size achieves a power of 0.8 under the assumption 
that the allele frequency is 0.35 and the allelic odds ratio is 1.61. Thus, it should be noted 
that the significant association is hard to be detected in this study if the -56T allele is truly 
but weakly associated with susceptibility to cerebral malaria in Thais. In Mandinka, the 
major Gambian ethnic group, heterozygote for -56C/T was found to be associated with 
protection against cerebral malaria (Koch et al. 2002). However, such a tendency or 
heterozygote advantage was not observed in the present study. The frequency of 
heterozygote was rather higher in cerebral malaria than in mild malaria (Table 1). Although 
this discrepancy may have been caused by ethnic difference or age difference of patients 
(i.e., children were studied in Mandinka), the association of -56C/T with cerebral malaria 
needs to be reexamined in further studies. A functional promoter polymorphism, IFNGR1 
-470insTT/delTT, previously shown to be associated with resistance to severe malaria 
(Koch et al. 2002; Koch et al. 2006) was not detected in the present variation screening. 
Five major SNP haplotypes were observed in Thai malaria patients (Fig. 1B). The 
comparison of haplotype frequencies between cerebral and mild malaria patients revealed 
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no significant association of the IFNGR1 haplotypes with cerebral malaria (data not 
shown). The analysis of LD in the IFNGR1 gene showed that six SNPs were in absolute 
LD (|D’| = 1) and three of them (1400T/C, 1676A/G, and 1687T/A) were in perfect LD (r2 = 
1; Fig. 1C). Since four SNPs indicated by the arrow in Figure 1B can act as tag SNPs for 
IFNGR1, these SNPs should be analyzed in future association studies in the Thai 
population. 
A total of 13 different alleles were observed at a microsatellite marker in intron 5 of 
IFNGR1 in Thai malaria patients (Table 2). Although a microsatellite allele with 18 repeats 
showed P-value of less than 0.05, this should not be regarded as statistically significant 
because a number of association tests were conducted in this study. Neither SNPs nor 
microsatellite marker demonstrated a significant deviation from Hardy-Weinberg 
equilibrium. 
In conclusion, we find no evidence for an association of IFNGR1 polymorphisms 
with cerebral malaria in Thais. 
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Figure legend 
 
Figure 1. Polymorphisms, haplotypes, and LD structure of IFNGR1. (A) The studied 
polymorphisms of IFNGR1 are herein presented. The shaded bar indicates the region 
subjected to variation screening. (B) The estimated frequencies of the haplotypes 
comprising six SNPs detected in this study. The arrow indicates tag SNP for IFNGR1 in 
the Thai population. (C) The pairwise LD values between six SNPs measured by r2. 
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